Structure

Physi-Chem Properties

Molecular Weight:  478.22
Volume:  466.74
LogP:  2.332
LogD:  1.312
LogS:  -4.334
# Rotatable Bonds:  4
TPSA:  136.43
# H-Bond Aceptor:  9
# H-Bond Donor:  2
# Rings:  5
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.45
Synthetic Accessibility Score:  6.611
Fsp3:  0.84
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.275
MDCK Permeability:  7.076184556353837e-05
Pgp-inhibitor:  0.993
Pgp-substrate:  0.041
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.012
30% Bioavailability (F30%):  0.923

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.651
Plasma Protein Binding (PPB):  65.79096221923828%
Volume Distribution (VD):  0.56
Pgp-substrate:  44.6480598449707%

ADMET: Metabolism

CYP1A2-inhibitor:  0.013
CYP1A2-substrate:  0.96
CYP2C19-inhibitor:  0.018
CYP2C19-substrate:  0.686
CYP2C9-inhibitor:  0.006
CYP2C9-substrate:  0.021
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.11
CYP3A4-inhibitor:  0.213
CYP3A4-substrate:  0.299

ADMET: Excretion

Clearance (CL):  6.286
Half-life (T1/2):  0.121

ADMET: Toxicity

hERG Blockers:  0.014
Human Hepatotoxicity (H-HT):  0.369
Drug-inuced Liver Injury (DILI):  0.655
AMES Toxicity:  0.012
Rat Oral Acute Toxicity:  0.151
Maximum Recommended Daily Dose:  0.032
Skin Sensitization:  0.156
Carcinogencity:  0.224
Eye Corrosion:  0.004
Eye Irritation:  0.012
Respiratory Toxicity:  0.889

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474906

Natural Product ID:  NPC474906
Common Name*:   Ailanthinone
IUPAC Name:   n.a.
Synonyms:   NSC-238187
Standard InCHIKey:  GCIFFNDSOLTCAI-ZTCIHUKBSA-N
Standard InCHI:  InChI=1S/C25H34O9/c1-6-10(2)20(29)34-17-16-12(4)18(27)25(31)22-23(5)13(11(3)7-14(26)19(23)28)8-15(33-21(17)30)24(16,22)9-32-25/h7,10,12-13,15-19,22,27-28,31H,6,8-9H2,1-5H3/t10?,12-,13+,15-,16-,17-,18-,19-,22-,23-,24+,25-/m1/s1
SMILES:  CCC(C)C(=O)O[C@@H]1[C@H]2[C@@H](C)[C@H]([C@@]3([C@@H]4[C@]5(C)[C@@H](C[C@H]([C@@]24CO3)OC1=O)C(=CC(=O)[C@H]5O)C)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL487194
PubChem CID:   44559321
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0002119] Quassinoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32507 odyendyea gabonensis Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[20738103]
NPO6324 Soulamea tomentosa Species Simaroubaceae Eukaryota n.a. n.a. n.a. PMID[7264678]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus T/C = 148.0 % PMID[518778]
NPT165 Cell Line HeLa Homo sapiens IC50 = 3.4 nM PMID[518779]
NPT90 Cell Line DU-145 Homo sapiens ED50 = 0.09 uM PMID[518781]
NPT81 Cell Line A549 Homo sapiens ED50 = 0.13 uM PMID[518781]
NPT91 Cell Line KB Homo sapiens ED50 = 0.18 uM PMID[518781]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 31000.0 nM PMID[518779]
NPT2 Others Unspecified INH = 0.42 uM PMID[518779]
NPT74 Individual Protein Proto-oncogene c-JUN Homo sapiens IC50 = 32.0 nM PMID[518779]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. GI50 = 31000.0 nM PMID[518780]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Inhibition < 25.0 % PMID[518779]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 0.37 uM PMID[518781]
NPT992 Organism Entamoeba histolytica Entamoeba histolytica IC50 = 0.063 ug.mL-1 PMID[518782]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474906 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC18547
0.9906 High Similarity NPC134869
0.9906 High Similarity NPC235539
0.9906 High Similarity NPC152199
0.981 High Similarity NPC289312
0.981 High Similarity NPC11252
0.9722 High Similarity NPC297179
0.9714 High Similarity NPC201992
0.9545 High Similarity NPC109607
0.9545 High Similarity NPC107338
0.9537 High Similarity NPC328374
0.9537 High Similarity NPC251236
0.9537 High Similarity NPC96312
0.9537 High Similarity NPC40632
0.9533 High Similarity NPC51978
0.9455 High Similarity NPC476529
0.9455 High Similarity NPC475775
0.9444 High Similarity NPC473798
0.9444 High Similarity NPC469877
0.9444 High Similarity NPC470919
0.9429 High Similarity NPC293850
0.9364 High Similarity NPC188667
0.9364 High Similarity NPC204552
0.9358 High Similarity NPC470628
0.9358 High Similarity NPC474046
0.9358 High Similarity NPC259306
0.9352 High Similarity NPC49451
0.9273 High Similarity NPC309433
0.9259 High Similarity NPC302146
0.9211 High Similarity NPC470922
0.9196 High Similarity NPC112038
0.9189 High Similarity NPC17772
0.9151 High Similarity NPC3316
0.9151 High Similarity NPC144854
0.9115 High Similarity NPC477046
0.9115 High Similarity NPC102822
0.9107 High Similarity NPC469488
0.9099 High Similarity NPC473968
0.9099 High Similarity NPC470854
0.9099 High Similarity NPC97908
0.9099 High Similarity NPC122033
0.9099 High Similarity NPC287343
0.9099 High Similarity NPC474654
0.9083 High Similarity NPC474516
0.9065 High Similarity NPC277017
0.9065 High Similarity NPC154608
0.9065 High Similarity NPC192813
0.9009 High Similarity NPC474734
0.9 High Similarity NPC7921
0.9 High Similarity NPC208998
0.8981 High Similarity NPC143706
0.8981 High Similarity NPC472534
0.8938 High Similarity NPC470777
0.8929 High Similarity NPC473590
0.8879 High Similarity NPC102352
0.8839 High Similarity NPC16081
0.8839 High Similarity NPC173686
0.8818 High Similarity NPC146945
0.8818 High Similarity NPC171888
0.8807 High Similarity NPC27814
0.8803 High Similarity NPC285091
0.8793 High Similarity NPC265557
0.8793 High Similarity NPC18945
0.8793 High Similarity NPC67251
0.8793 High Similarity NPC105926
0.8793 High Similarity NPC227397
0.8793 High Similarity NPC91693
0.8772 High Similarity NPC127530
0.8772 High Similarity NPC473920
0.875 High Similarity NPC243354
0.875 High Similarity NPC143268
0.875 High Similarity NPC323821
0.875 High Similarity NPC268238
0.875 High Similarity NPC102088
0.875 High Similarity NPC45218
0.8727 High Similarity NPC210005
0.8718 High Similarity NPC476729
0.8718 High Similarity NPC24651
0.8707 High Similarity NPC312833
0.8707 High Similarity NPC471965
0.8704 High Similarity NPC181357
0.8684 High Similarity NPC251310
0.8684 High Similarity NPC470776
0.8673 High Similarity NPC207217
0.8661 High Similarity NPC194100
0.8661 High Similarity NPC62696
0.8661 High Similarity NPC293038
0.8661 High Similarity NPC255017
0.8661 High Similarity NPC194273
0.8655 High Similarity NPC188291
0.8649 High Similarity NPC471243
0.8636 High Similarity NPC141350
0.8632 High Similarity NPC471961
0.8632 High Similarity NPC202666
0.8632 High Similarity NPC478066
0.8632 High Similarity NPC471964
0.8632 High Similarity NPC14617
0.8632 High Similarity NPC262199
0.8624 High Similarity NPC293512
0.8621 High Similarity NPC275675
0.8621 High Similarity NPC470779
0.8609 High Similarity NPC473401
0.8609 High Similarity NPC122971
0.8609 High Similarity NPC319570
0.8596 High Similarity NPC176513
0.8596 High Similarity NPC470775
0.8595 High Similarity NPC100390
0.8595 High Similarity NPC254614
0.8585 High Similarity NPC472972
0.8584 High Similarity NPC475633
0.8571 High Similarity NPC471967
0.8571 High Similarity NPC90769
0.8559 High Similarity NPC30188
0.8559 High Similarity NPC471962
0.8559 High Similarity NPC247315
0.8559 High Similarity NPC177820
0.8559 High Similarity NPC470477
0.8559 High Similarity NPC474567
0.8559 High Similarity NPC471963
0.8547 High Similarity NPC249848
0.8547 High Similarity NPC40775
0.8547 High Similarity NPC235438
0.8547 High Similarity NPC107966
0.8545 High Similarity NPC272576
0.8534 High Similarity NPC471406
0.8522 High Similarity NPC286347
0.8519 High Similarity NPC275583
0.8512 High Similarity NPC262796
0.8512 High Similarity NPC329993
0.8512 High Similarity NPC134914
0.8512 High Similarity NPC172374
0.8512 High Similarity NPC475377
0.8512 High Similarity NPC173435
0.8512 High Similarity NPC45346
0.8512 High Similarity NPC475167
0.8512 High Similarity NPC478065
0.8512 High Similarity NPC264566
0.8512 High Similarity NPC476074
0.8512 High Similarity NPC301639
0.8512 High Similarity NPC478064
0.85 High Similarity NPC295220
0.85 High Similarity NPC475636
0.8496 Intermediate Similarity NPC320118
0.8487 Intermediate Similarity NPC47113
0.8487 Intermediate Similarity NPC174367
0.8487 Intermediate Similarity NPC87662
0.8482 Intermediate Similarity NPC263827
0.8482 Intermediate Similarity NPC285410
0.8482 Intermediate Similarity NPC250481
0.8475 Intermediate Similarity NPC235405
0.8475 Intermediate Similarity NPC30735
0.8475 Intermediate Similarity NPC281148
0.8468 Intermediate Similarity NPC310546
0.8462 Intermediate Similarity NPC75417
0.8462 Intermediate Similarity NPC202051
0.8455 Intermediate Similarity NPC230541
0.8448 Intermediate Similarity NPC309780
0.8448 Intermediate Similarity NPC469945
0.8448 Intermediate Similarity NPC11551
0.8448 Intermediate Similarity NPC39211
0.8448 Intermediate Similarity NPC114441
0.8448 Intermediate Similarity NPC157868
0.8448 Intermediate Similarity NPC473884
0.8448 Intermediate Similarity NPC475171
0.8448 Intermediate Similarity NPC208381
0.8448 Intermediate Similarity NPC180550
0.8448 Intermediate Similarity NPC214484
0.8448 Intermediate Similarity NPC192791
0.8448 Intermediate Similarity NPC472949
0.8448 Intermediate Similarity NPC6377
0.8448 Intermediate Similarity NPC279143
0.8448 Intermediate Similarity NPC35405
0.8443 Intermediate Similarity NPC478153
0.8443 Intermediate Similarity NPC478152
0.8443 Intermediate Similarity NPC471855
0.8443 Intermediate Similarity NPC478150
0.8443 Intermediate Similarity NPC102316
0.844 Intermediate Similarity NPC475036
0.844 Intermediate Similarity NPC65523
0.8435 Intermediate Similarity NPC477252
0.8435 Intermediate Similarity NPC224121
0.843 Intermediate Similarity NPC54614
0.843 Intermediate Similarity NPC309096
0.8421 Intermediate Similarity NPC472274
0.8417 Intermediate Similarity NPC470780
0.8407 Intermediate Similarity NPC477253
0.8407 Intermediate Similarity NPC280782
0.8407 Intermediate Similarity NPC116794
0.8407 Intermediate Similarity NPC472002
0.8407 Intermediate Similarity NPC474927
0.8407 Intermediate Similarity NPC130427
0.8403 Intermediate Similarity NPC473255
0.84 Intermediate Similarity NPC596
0.8393 Intermediate Similarity NPC102914
0.8393 Intermediate Similarity NPC274507
0.8393 Intermediate Similarity NPC474786
0.8393 Intermediate Similarity NPC220984
0.8393 Intermediate Similarity NPC199457
0.8393 Intermediate Similarity NPC137104
0.8393 Intermediate Similarity NPC75747

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474906 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8632 High Similarity NPD8328 Phase 3
0.8276 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.825 Intermediate Similarity NPD7492 Approved
0.8246 Intermediate Similarity NPD8297 Approved
0.8246 Intermediate Similarity NPD6882 Approved
0.822 Intermediate Similarity NPD6319 Approved
0.822 Intermediate Similarity NPD6059 Approved
0.822 Intermediate Similarity NPD6054 Approved
0.8198 Intermediate Similarity NPD6402 Approved
0.8198 Intermediate Similarity NPD5739 Approved
0.8198 Intermediate Similarity NPD7128 Approved
0.8198 Intermediate Similarity NPD6675 Approved
0.8197 Intermediate Similarity NPD7736 Approved
0.8182 Intermediate Similarity NPD6616 Approved
0.8142 Intermediate Similarity NPD6372 Approved
0.8142 Intermediate Similarity NPD6373 Approved
0.8142 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD6412 Phase 2
0.812 Intermediate Similarity NPD6009 Approved
0.8115 Intermediate Similarity NPD8293 Discontinued
0.8115 Intermediate Similarity NPD7078 Approved
0.8083 Intermediate Similarity NPD6370 Approved
0.8053 Intermediate Similarity NPD6881 Approved
0.8053 Intermediate Similarity NPD7320 Approved
0.8053 Intermediate Similarity NPD6899 Approved
0.8017 Intermediate Similarity NPD4632 Approved
0.8 Intermediate Similarity NPD6016 Approved
0.8 Intermediate Similarity NPD6649 Approved
0.8 Intermediate Similarity NPD6015 Approved
0.8 Intermediate Similarity NPD6650 Approved
0.7965 Intermediate Similarity NPD5701 Approved
0.7965 Intermediate Similarity NPD5697 Approved
0.7934 Intermediate Similarity NPD5988 Approved
0.7913 Intermediate Similarity NPD7102 Approved
0.7913 Intermediate Similarity NPD6883 Approved
0.7913 Intermediate Similarity NPD7290 Approved
0.7895 Intermediate Similarity NPD6686 Approved
0.7886 Intermediate Similarity NPD7507 Approved
0.7845 Intermediate Similarity NPD6617 Approved
0.7845 Intermediate Similarity NPD6847 Approved
0.7845 Intermediate Similarity NPD6869 Approved
0.7845 Intermediate Similarity NPD8130 Phase 1
0.7826 Intermediate Similarity NPD6014 Approved
0.7826 Intermediate Similarity NPD6012 Approved
0.7826 Intermediate Similarity NPD6013 Approved
0.7739 Intermediate Similarity NPD6011 Approved
0.7739 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7724 Intermediate Similarity NPD7604 Phase 2
0.7705 Intermediate Similarity NPD5983 Phase 2
0.7698 Intermediate Similarity NPD7319 Approved
0.7692 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD6033 Approved
0.7615 Intermediate Similarity NPD7748 Approved
0.76 Intermediate Similarity NPD6336 Discontinued
0.7593 Intermediate Similarity NPD7515 Phase 2
0.7568 Intermediate Similarity NPD6084 Phase 2
0.7568 Intermediate Similarity NPD6083 Phase 2
0.7568 Intermediate Similarity NPD7902 Approved
0.7568 Intermediate Similarity NPD4755 Approved
0.7565 Intermediate Similarity NPD6008 Approved
0.7521 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD4634 Approved
0.7438 Intermediate Similarity NPD6274 Approved
0.7434 Intermediate Similarity NPD5285 Approved
0.7434 Intermediate Similarity NPD5286 Approved
0.7434 Intermediate Similarity NPD4700 Approved
0.7434 Intermediate Similarity NPD4696 Approved
0.7407 Intermediate Similarity NPD5328 Approved
0.7398 Intermediate Similarity NPD7101 Approved
0.7398 Intermediate Similarity NPD7516 Approved
0.7398 Intermediate Similarity NPD7100 Approved
0.7377 Intermediate Similarity NPD7115 Discovery
0.7364 Intermediate Similarity NPD6399 Phase 3
0.7345 Intermediate Similarity NPD7638 Approved
0.7321 Intermediate Similarity NPD5222 Approved
0.7321 Intermediate Similarity NPD5221 Approved
0.7321 Intermediate Similarity NPD4697 Phase 3
0.7321 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD6335 Approved
0.7317 Intermediate Similarity NPD7327 Approved
0.7317 Intermediate Similarity NPD7328 Approved
0.7315 Intermediate Similarity NPD6672 Approved
0.7315 Intermediate Similarity NPD5737 Approved
0.7311 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7304 Intermediate Similarity NPD5225 Approved
0.7304 Intermediate Similarity NPD4633 Approved
0.7304 Intermediate Similarity NPD5226 Approved
0.7304 Intermediate Similarity NPD5224 Approved
0.7304 Intermediate Similarity NPD5211 Phase 2
0.7297 Intermediate Similarity NPD7900 Approved
0.7297 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7295 Intermediate Similarity NPD6868 Approved
0.7281 Intermediate Similarity NPD7639 Approved
0.7281 Intermediate Similarity NPD7640 Approved
0.728 Intermediate Similarity NPD8033 Approved
0.728 Intermediate Similarity NPD8517 Approved
0.728 Intermediate Similarity NPD6908 Approved
0.728 Intermediate Similarity NPD8515 Approved
0.728 Intermediate Similarity NPD8516 Approved
0.728 Intermediate Similarity NPD6909 Approved
0.728 Intermediate Similarity NPD8513 Phase 3
0.7273 Intermediate Similarity NPD8133 Approved
0.7273 Intermediate Similarity NPD6079 Approved
0.7265 Intermediate Similarity NPD4768 Approved
0.7265 Intermediate Similarity NPD4767 Approved
0.7257 Intermediate Similarity NPD5173 Approved
0.7241 Intermediate Similarity NPD5175 Approved
0.7241 Intermediate Similarity NPD5174 Approved
0.7236 Intermediate Similarity NPD6317 Approved
0.7232 Intermediate Similarity NPD5695 Phase 3
0.7222 Intermediate Similarity NPD3573 Approved
0.7217 Intermediate Similarity NPD5223 Approved
0.72 Intermediate Similarity NPD8294 Approved
0.72 Intermediate Similarity NPD8377 Approved
0.7193 Intermediate Similarity NPD4225 Approved
0.7193 Intermediate Similarity NPD5696 Approved
0.7179 Intermediate Similarity NPD5141 Approved
0.7177 Intermediate Similarity NPD6314 Approved
0.7177 Intermediate Similarity NPD6313 Approved
0.7165 Intermediate Similarity NPD6067 Discontinued
0.7143 Intermediate Similarity NPD8380 Approved
0.7143 Intermediate Similarity NPD8335 Approved
0.7143 Intermediate Similarity NPD7503 Approved
0.7143 Intermediate Similarity NPD4730 Approved
0.7143 Intermediate Similarity NPD8379 Approved
0.7143 Intermediate Similarity NPD8378 Approved
0.7143 Intermediate Similarity NPD6921 Approved
0.7143 Intermediate Similarity NPD8296 Approved
0.7143 Intermediate Similarity NPD4729 Approved
0.713 Intermediate Similarity NPD3618 Phase 1
0.7117 Intermediate Similarity NPD6411 Approved
0.7107 Intermediate Similarity NPD8413 Clinical (unspecified phase)
0.7094 Intermediate Similarity NPD4754 Approved
0.7059 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD46 Approved
0.7027 Intermediate Similarity NPD6698 Approved
0.7025 Intermediate Similarity NPD5251 Approved
0.7025 Intermediate Similarity NPD5250 Approved
0.7025 Intermediate Similarity NPD5249 Phase 3
0.7025 Intermediate Similarity NPD5248 Approved
0.7025 Intermediate Similarity NPD5247 Approved
0.7008 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD5128 Approved
0.7 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.6972 Remote Similarity NPD7334 Approved
0.6972 Remote Similarity NPD6409 Approved
0.6972 Remote Similarity NPD7146 Approved
0.6972 Remote Similarity NPD5330 Approved
0.6972 Remote Similarity NPD6684 Approved
0.6972 Remote Similarity NPD7521 Approved
0.6944 Remote Similarity NPD4786 Approved
0.6937 Remote Similarity NPD6673 Approved
0.6937 Remote Similarity NPD6904 Approved
0.6937 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6937 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6937 Remote Similarity NPD6080 Approved
0.6937 Remote Similarity NPD6101 Approved
0.6937 Remote Similarity NPD4753 Phase 2
0.6917 Remote Similarity NPD7260 Phase 2
0.6916 Remote Similarity NPD3667 Approved
0.6903 Remote Similarity NPD4202 Approved
0.6891 Remote Similarity NPD8170 Clinical (unspecified phase)
0.687 Remote Similarity NPD8074 Phase 3
0.6847 Remote Similarity NPD6903 Approved
0.6842 Remote Similarity NPD5956 Approved
0.6842 Remote Similarity NPD5282 Discontinued
0.6829 Remote Similarity NPD5215 Approved
0.6829 Remote Similarity NPD5216 Approved
0.6829 Remote Similarity NPD5217 Approved
0.6814 Remote Similarity NPD8034 Phase 2
0.6814 Remote Similarity NPD8035 Phase 2
0.6789 Remote Similarity NPD3666 Approved
0.6789 Remote Similarity NPD3133 Approved
0.6789 Remote Similarity NPD3665 Phase 1
0.6783 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6774 Remote Similarity NPD6053 Discontinued
0.6754 Remote Similarity NPD5779 Approved
0.6754 Remote Similarity NPD5778 Approved
0.6748 Remote Similarity NPD5169 Approved
0.6748 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6748 Remote Similarity NPD5135 Approved
0.6741 Remote Similarity NPD6845 Suspended
0.6729 Remote Similarity NPD4695 Discontinued
0.6727 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6723 Remote Similarity NPD7632 Discontinued
0.6721 Remote Similarity NPD5168 Approved
0.6694 Remote Similarity NPD5127 Approved
0.6667 Remote Similarity NPD6098 Approved
0.6667 Remote Similarity NPD5279 Phase 3
0.6667 Remote Similarity NPD7983 Approved
0.6667 Remote Similarity NPD5693 Phase 1
0.6667 Remote Similarity NPD6050 Approved
0.6639 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6639 Remote Similarity NPD5344 Discontinued
0.6638 Remote Similarity NPD4629 Approved
0.6638 Remote Similarity NPD5210 Approved
0.6619 Remote Similarity NPD6333 Approved
0.6619 Remote Similarity NPD6334 Approved
0.6579 Remote Similarity NPD5692 Phase 3
0.6577 Remote Similarity NPD5329 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data